169
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension

, , , , , & show all
Pages 629-636 | Published online: 13 Nov 2009

References

  • KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol20021206701713discussion 829–83012049574
  • HeijlALeskeMCBengtssonBHymanLBengtssonBHusseinMReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol2002120101268127912365904
  • FechtnerRDRealiniTFixed combinations of topical glaucoma medicationsCurr Opin Ophthalmol200415213213515021225
  • SchumanJSKatzGJLewisRAEfficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertensionAm J Ophthalmol2005140224225016086946
  • HughesBABacharachJCravenERA three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertensionJ Glaucoma200514539239916148589
  • BarnebeyHSOrengo-NaniaSFlowersBEThe safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solutionAm J Ophthalmol200514011715990081
  • BoyleJEGhoshKGieserDKAdamsonsIAA randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study GroupOphthalmology199810510194519519787368
  • AsraniSZeimerRWilenskyJGieserDVitaleSLindenmuthKLarge diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucomaJ Glaucoma20009213414210782622
  • BergeaBBodinLSvedberghBImpact of intraocular pressure regulation on visual fields in open-angle glaucomaOphthalmology199910659971004discussion 1004–100510328403
  • SuzukiERJrFranklinLMda SilvaLJFigueiredoCRNettoJABatistaWDComparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertensionCurr Med Res Opin20062291799180516968583
  • ChiselițăDAntohiIMedvichiRDanielescuCComparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design studyOftalmologia2005493394516408674
  • LafumaABerdeauxGCosts and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research DatabaseCurr Med Res Opin200723123009301617958945
  • LeskeMCHeijlAHymanLBengtssonBDongLYangZPredictors of long-term progression in the early manifest glaucoma trialOphthalmology2007114111965197217628686
  • LippaEACarlsonLEEhingerBDose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitorArch Ophthalmol199211044954991562255
  • GrossRLPeaceJHSmithSEDuration of IOP reduction with travoprost BAK-free solutionJ Glaucoma200817321722218414108
  • PatelSCSpaethGLCompliance in patients prescribed eyedrops for glaucomaOphthalmic Surg19952632332367651690